Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-784-4 | CAS number: 110-62-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 1977
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- deviations from test guideline: only 2 animals tested, dose applicated 0.05 mL, no grading of eye reaction at 72 h
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Reference
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- An internal BASF method was used which was in large part equivalent to OECD guideline 401
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: mean 170 g (male), 150 g (female)
- Diet (e.g. ad libitum): ad libitum, Altronin R 1121
- Water (e.g. ad libitum): tap water, ad libitum - Route of administration:
- oral: gavage
- Vehicle:
- other: 0.5% CMC with Cremophor EL
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 46.4, 50%
- Amount of vehicle (if gavage): 20 mL/kg bw
MAXIMUM DOSE VOLUME APPLIED: 3.4 mL - Doses:
- 4640, 6810, 10000 µL/kg bw (approx. 3763, 5522, 8109 mg/kg bw based on a density of 0.8109 g/mL)
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily observations and weighing prior to study and days 2, 7 and 13
- Necropsy of survivors performed: yes - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 6 490 mg/kg bw
- Remarks on result:
- other: LD 50 converted from the orignally reported value of 8 mL/kg bw (based on a density of 0.8109 g/ml)
- Mortality:
- 4640 µl/kg bw (3763 mg/kg bw): no mortality
6810 µl/kg bw (5522 mg/kg bw): 2/5 males within 24 h; 1/5 females within 24 h
10000 µl/kg bw (8109 mg/kg bw): 4/5 males within 24 h; 4/5 females within 24 h - Clinical signs:
- other: dyspnoea, apathy, face-down, lateral and dorsal position, staggering, atony, narcosis-like state with loss of pain- and corneal reflex, spastic move, exsiccosis, exophtalmus, reduced general state
- Gross pathology:
- heart: acute bilateral dilatation, congestive hyperemia
stomach: gastroesophageal vestibule septum thickened and sclerotic, agglutination, cauterisation gastritis - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute oral LD50 of valeraldehyde was determined to be 6490 mg/kg bw. No classification is required according to EU CLP (1272/2008/EC) not met.
- Executive summary:
The acute oral toxicity of valeraldehyde was determined in groups of 5 male and 5 female Sprague-Dawley rats receiving the test material by oral gavage at doses of 3760, 5520, 8110 mg/kg bw. The observation period was 14 days. The LD50 was estimated using a graphical evaluation of the dose response curve on probability paper. Overall, the study was conducted in accordance with the recently retracted OECD test guideline 401.
The acute oral LD50 was determined to be 6490 mg/kg bw in rats (BASF, 1977).
Mean weights:
dose (µl/kg bw) | sex | mean weight (g) | |||
prior to study | d 2 | d 7 | d 13 | ||
10000 | m | 170 | 176 | 194 | 223 |
f | 150 | 156 | 176 | 188 | |
6810 | m | 170 | 181 | 252 | 252 |
f | 150 | 152 | 190 | 190 | |
4640 | m | 170 | 194 | 225 | 242 |
f | 150 | 171 | 183 | 194 |
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 977
- Report date:
- 1977
Materials and methods
- Principles of method if other than guideline:
- An internal BASF method was used (deviations from OECD test guideline: only 2 animals tested, dose applicated 0.05 mL, no grading of eye reaction at 72 h)
- GLP compliance:
- no
Test material
- Reference substance name:
- Valeraldehyde
- EC Number:
- 203-784-4
- EC Name:
- Valeraldehyde
- Cas Number:
- 110-62-3
- Molecular formula:
- C5H10O
- IUPAC Name:
- pentanal
- Test material form:
- liquid
- Details on test material:
- - Name of test material (as cited in study report): n-Valeraldehyd
- Substance No.: XXVI 30
Constituent 1
Test animals / tissue source
- Species:
- rabbit
- Strain:
- Vienna White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: Gaukler
- Weight at study initiation: 2.78, 3.06 kg
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- other: NaCl-treated eye of same animal
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.05 ml
- Concentration (if solution): 100% - Duration of treatment / exposure:
- one application
- Observation period (in vivo):
- 8 days
- Number of animals or in vitro replicates:
- 2
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing (if done): no
SCORING SYSTEM:
The original BASF grading was converted into the numerical grading according to the OECD Draize system:
Cornea
(A) Opacity-degree of density (area most dense taken for reading)
0 = No opacity
1 = Scattered or diffuse area, details of iris clearly visible
2 = Easily discernible translucent areas, details of iris slightly obscured
3 = Opalescent areas, no details of iris visible, size of pupil barely discernible
4 = Opaque, iris invisible
(B) Area of cornea involved
1 = One quarter (or less) but not zero
2 = Greater than one quarter, but less than half
3 = Greater than half, but less than three quarters
4 = Greater than three quarters, up to whole area
Iris
(A) Values
0 = Normal
1 = Folds above normal, congestion, swelling, circumcorneal injection (any or all of these or combination af any thereof) iris still reacting to light (sluggish reactions is positive)
2 = No reaction to light, hemorrhage, gross destruction (any or all of these)
(3) Conjunctivae
(A) Redness (refers to palpebral and bulbar conjunctivae excluding cornea and iris)
0 = Vessels normal
1 = Vessels definitely injected above normal
2 = More diffuse, deeper crimson red, individual vessels not easily discernible
3 = Diffuse beefy red
(B) Chemosis
0 = No swelling
1 = Any swelling above normal (includes nictitatinq membrane)
2 = Obvious swelling with partial eversion of lids
3 = Swelling with lids about half closed
4 = Swelling with lids about half closed to completely closed
(C) Discharge
0 = No discharge
1 = Any amount different from normal (does not include small amounts observed in inner canthus of normal animals)
2 = Discharge with moistening of the lids and hairs just adjacent to lids
3 = Discharge with moistening of the lids and hairs, and considerable area around the eye
TOOL USED TO ASSESS SCORE: fluorescein at day 8
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- chemosis score
- Basis:
- animal #1
- Time point:
- 24/48 h
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- fully reversible within: 5 days
- Remarks on result:
- probability of weak irritation
- Irritation parameter:
- chemosis score
- Basis:
- animal #2
- Time point:
- 24/48 h
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- fully reversible within: 5 days
- Remarks on result:
- probability of weak irritation
- Irritation parameter:
- iris score
- Basis:
- animal #1
- Time point:
- 24/48 h
- Score:
- 0
- Max. score:
- 2
- Reversibility:
- other: no effect observed
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- iris score
- Basis:
- animal #2
- Time point:
- 24/48 h
- Score:
- 0
- Max. score:
- 2
- Reversibility:
- other: no effect observed
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- cornea opacity score
- Basis:
- animal #1
- Time point:
- 24/48 h
- Score:
- 0.5
- Max. score:
- 4
- Reversibility:
- fully reversible within: 48h
- Remarks on result:
- probability of weak irritation
- Irritation parameter:
- cornea opacity score
- Basis:
- animal #2
- Time point:
- 24/48 h
- Score:
- 1.5
- Max. score:
- 4
- Reversibility:
- fully reversible within: 8 d
- Remarks on result:
- probability of weak irritation
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #1
- Time point:
- 24/48 h
- Score:
- 1.5
- Max. score:
- 3
- Reversibility:
- fully reversible within: 5 d
- Remarks on result:
- probability of weak irritation
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #2
- Time point:
- 24/48 h
- Score:
- 2
- Max. score:
- 3
- Reversibility:
- fully reversible within: 7
- Remarks on result:
- probability of weak irritation
Any other information on results incl. tables
Readings | Animal | Corneal opacity | Iris | conjunctiva | ||
Erythema | Chemosis | Additional findings | ||||
1h | 1 | 1 | 0 | 1 | 2 | |
2 | 1 | 0 | 1 | 2 | o | |
3 h | 1 | 1 | 0 | 1 | 2 | o |
2 | 1 | 0 | 1 | 2 | o | |
24 h | 1 | 1 | 0 | 2 | 1 | o, s |
2 | 1 | 0 | 2 | 1 | o | |
48 h | 1 | 0 | 0 | 1 | 1 | o, s |
2 | 2 | 0 | 2 | 1 | o | |
5 d | 1 | 0 | 0 | 0 | 0 | |
2 | 1 | 0 | 1 | 0 | o | |
7 d | 1 | 0 | 0 | 0 | 0 | |
2 | 1 | 0 | 0 | 0 | ||
8 d | 1 | 0 | 0 | 0 | 0 | |
2 | 0 | 0 | 0 | 0 | ||
Mean 24 - 48 h | 1 | 0.5 | 0.0 | 1.5 | 1.0 | |
2 | 1.5 | 0.0 | 2.0 | 1.0 | ||
Mean | 1.0 | 0.0 | 1.8 | 1.0 |
o: smudgy overlay
s: scar
Applicant's summary and conclusion
- Interpretation of results:
- Category 2 (irritating to eyes) based on GHS criteria
- Conclusions:
- After application of 0.05 mL of test substance to 2 rabbit eyes, mean (24 and 48 h, no reading at 72 h) cornea scores of 0.5 and 1.5 and conjunctivae scores of 1.5 and 2 were observed for the two test animals respectively. All effects were fully reversible within 8 d at the maximum. For one rabbit, classification criteria of regulation (EC) No 1272/2008 for reversible effects on the eye (Category 2) are reached or exceeded. Considering the time course of cornea scores for rabbit 2, mean cornea score will be > 1 even if a 72 h reading were available. In addition, the amount of the dose applied (0.05 mL instead of 0.1 mL according to EU test guideline) has to be allowed for. It is estimated that with the higher dose, the reversibility of effects still will be maintained but the scores will be elevated. Thus, valeraldehyde is assessed to be irritating to the eye (Category 2) according to EU regulations.
- Executive summary:
In an acute eye irritation/corrosion test, 2 rabbits were exposed to 0.05 mL valeraldehyde each. Irritation reactions of cornea and conjunctivae developed within 1 hour after application and persisted up to a maximum of 8 days. At the end of the observation period (8 days) all irritation effects had subsided.
For rabbit 1, the mean (24 and 48 h, no reading at 72 h) cornea and conjunctivae scores were 0.5 and 1.5 respectively. For rabbit 2, the mean cornea and conjunctivae scores were 1.5 and 2 thus exceeded or reaching the EU criteria for classification (reversible effect on the eye - Category 2) (BASF 1977). Considering the dose applied and the time course of the development of irritating effects, valeraldehyde requires classification as irritating to eyes (Category 2).
For recent primary eye irritation tests in vivo, test guidelines require the application of 0.1 mL test substance. Considering the data available and the time course of the eye irritating effects, it is estimated that with the higher dose, scores will be elevated but still remain below the criteria for irreversible effects and the reversibility of effects within 21 days will be maintained. Based on the data available, valeraldehyde will be classified as irritating to eyes (Category 2).
This study bears some deviations from actual test guidelines. Nevertheless, the data are assessed to be sufficiently valid to evaluate the eye irritation potential of valeraldehyde. Using available results conforms to the tiered testing and evaluation strategy for eye irritation/corrosion and further testing can be avoided.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.